Login / Signup

Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.

Alex Hoerby ChristensenPyotr G PlatonovAnneli SvenssonHenrik K JensenChristine Rootwelt-NorbergPia DahlbergTrine MadsenTanja Charlotte FrederiksenTiina HeliöKristina H HaugaaHenning BundgaardJesper H Svendsen
Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
Forty-one percent of ARVC patients treated with ICD experienced potentially life-saving ICD therapy during long-term follow-up. A third of the patients experienced a complication during follow-up with lead-related complications constituting the vast majority.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • heart failure
  • prognostic factors
  • combination therapy
  • smoking cessation
  • childhood cancer